Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check6 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.7, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check13 days agoChange DetectedThe service alert has been updated to reflect a planned maintenance starting on July 25th, with most services being unavailable for over 24 hours beginning at 9 PM EDT. The revision number has also changed from v2.16.5 to v2.16.6.SummaryDifference0.2%
- Check20 days agoChange DetectedA service alert has been added regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.SummaryDifference0.6%
- Check28 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.7%
- Check35 days agoChange DetectedThe webpage has been updated to include new results and definitions related to the clinical study, specifically detailing the progression-free survival (PFS), overall survival (OS), and objective response rate (ORR) for various treatment arms, including the Ferrell-Duncan Clinic. Additionally, the results reporting dates have been updated.SummaryDifference38%
- Check42 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.